Previous studies have shown that
iron accumulation is involved in the pathogenesis of
brain injury following
subarachnoid hemorrhage (SAH) and chelation of
iron reduced mortality and oxidative DNA damage. We previously reported that blockage of
mitochondrial calcium uniporter (MCU) provided benefit in the early
brain injury after experimental SAH. This study was undertaken to identify whether blockage of MCU could ameliorate
iron accumulation-associated
brain injury following SAH. Therefore, we used two
reagents ruthenium red (RR) and
spermine (Sper) to inhibit MCU. Sprague-Dawley (SD) rats were randomly divided into four groups including
sham, SAH, SAH+RR, and SAH+Sper. Biochemical analysis and histological assays were performed. The results confirmed the
iron accumulation in temporal lobe after SAH. Interestingly, blockage of MCU dramatically reduced the
iron accumulation in this area. The mechanism was revealed that inhibition of MCU reversed the down-regulation of
iron regulatory protein (
IRP) 1/2 and increase of
ferritin.
Iron-
sulfur cluster dependent-
aconitase activity was partially conserved when MCU was blocked. In consistence with this and previous report, ROS levels were notably reduced and
ATP supply was rescued; levels of cleaved
caspase-3 dropped; and integrity of neurons in temporal lobe was protected. Taken together, our results indicated that blockage of MCU could alleviate
iron accumulation and the associated injury following SAH. These findings suggest that the alteration of
calcium and
iron homeostasis be coupled and MCU be considered to be a therapeutic target for patients suffering from SAH.